One‐year persistence of neutralizing anti‐SARS‐CoV‐2 antibodies in dialysis patients recovered from COVID‐19
The immunological mechanisms that modulate immune response to SARS‐CoV‐2 infection
remain elusive. Little is known on the magnitude and the durability of antibody response …
remain elusive. Little is known on the magnitude and the durability of antibody response …
[HTML][HTML] Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19
G Alfano, N Morisi, M Frisina, A Ferrari… - Le Infezioni in …, 2022 - ncbi.nlm.nih.gov
COVID-19 is an unpredictable infectious disease caused by SARS-CoV-2. The development
of effective anti-COVID-19 vaccines has enormously minimized the risk of severe illness in …
of effective anti-COVID-19 vaccines has enormously minimized the risk of severe illness in …
[HTML][HTML] Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19
…, C Ferri, A Melluso, M Montani, N Morisi… - G Ital …, 2021 - giornaleitalianodinefrologia.it
Background: Kidney transplant (KT) recipients with COVID-19 are at high risk of poor
outcomes due to the high burden of comorbidities and immunosuppression. The effects of …
outcomes due to the high burden of comorbidities and immunosuppression. The effects of …
Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis
G Alfano, F Fontana, N Morisi, G Mori… - Clinical Kidney …, 2022 - academic.oup.com
Insufficient vaccine coverage and dominance of the more transmissible severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are the leading causes of the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are the leading causes of the …
Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review
Introduction: Cell-free nucleic acids (cf-NAs) represent a promising biomarker of various
pathological and physiological conditions. Since its discovery in 1948, cf-NAs gained prognostic …
pathological and physiological conditions. Since its discovery in 1948, cf-NAs gained prognostic …
[HTML][HTML] Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience
G Alfano, F Fontana, S Giovanella, N Morisi… - Clinical and …, 2023 - Springer
Introduction There are limited data on the effects of COVID-19 on peritoneal dialysis (PD)
patients. This study aimed to describe the impact of COVID-19 on the PD population. Methods …
patients. This study aimed to describe the impact of COVID-19 on the PD population. Methods …
Which criteria should we use to end isolation in hemodialysis patients with COVID-19?
G Alfano, F Fontana, A Ferrari, N Morisi… - Clinical Kidney …, 2022 - academic.oup.com
Safe and timely discontinuation of quarantine of in-center hemodialysis (HD) patients with a
previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a …
previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a …
[HTML][HTML] Criticality of neuronal avalanches in human sleep and their relationship with sleep macro-and micro-architecture
S Scarpetta, N Morisi, C Mutti, N Azzi, I Trippi… - Iscience, 2023 - Elsevier
Sleep plays a key role in preserving brain function, keeping brain networks in a state that
ensures optimal computation. Empirical evidence indicates that this state is consistent with …
ensures optimal computation. Empirical evidence indicates that this state is consistent with …
Peritoneal Inflammation in PD-Related Peritonitis Induces Systemic Eryptosis: In Vitro and In Vivo Assessments
GM Virzì, N Morisi, D Marturano… - International Journal of …, 2024 - mdpi.com
Erythrocytes (RBCs) have a highly specialized and organized membrane structure and
undergo programmed cell death, known as eryptosis. Our preliminary data show a significant …
undergo programmed cell death, known as eryptosis. Our preliminary data show a significant …
Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients
G Alfano, N Morisi, S Giovanella… - The Journal of …, 2024 - journals.sagepub.com
Patients requiring dialysis are extremely vulnerable to infectious diseases. The high burden
of comorbidities and weakened immune system due to uremia and previous …
of comorbidities and weakened immune system due to uremia and previous …